Advent To Buy Suven Pharma In A Rs 9,589-Crore Deal

NDTV Profit 2022-12-26

Views 2

Global private equity firm Advent International will acquire a 50.1% stake in Suven Pharma, buying 12.75 crore shares for a total of Rs 6,313 crore. Suven Pharma MD Venkateswarlu Jasti discusses the acquisition.

Share This Video


Download

  
Report form